Search by Drug Name or NDC
NDC 53746-0254-02 Ranitidine 300 mg/1 Details
Ranitidine 300 mg/1
Ranitidine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is RANITIDINE HYDROCHLORIDE.
Product Information
| NDC | 53746-0254 |
|---|---|
| Product ID | 53746-254_8625e9c6-6542-43d2-a657-34161884a7d0 |
| Associated GPIs | 49200020100310 |
| GCN Sequence Number | 011674 |
| GCN Sequence Number Description | ranitidine HCl TABLET 300 MG ORAL |
| HIC3 | Z2D |
| HIC3 Description | HISTAMINE H2-RECEPTOR INHIBITORS |
| GCN | 10201 |
| HICL Sequence Number | 004520 |
| HICL Sequence Number Description | RANITIDINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Ranitidine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ranitidine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/1 |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Labeler Name | Amneal Pharmaceuticals of New York LLC |
| Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077824 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 53746-0254-02 (53746025402)
| NDC Package Code | 53746-254-02 |
|---|---|
| Billing NDC | 53746025402 |
| Package | 250 TABLET in 1 BOTTLE (53746-254-02) |
| Marketing Start Date | 2009-12-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |